The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Updates of Spondyloarthrothy Treatment

척추관절병증의 치료에 대한 최신지견

  • Kim, Tae-Hwan (Department of Rheumatology, Hanyang University Hospital for Rheumatic Disease)
  • 김태환 (한양대학교 류마티스병원 류마티스내과)
  • Published : 2013.09.01
⟨ Previous Next ⟩

Abstract

The goals of treatment in Spondyloarthropathy are to reduce pain and stiffness, and to maintain good quality of life. Regular exercise with stretching of axial skeleton is most important. No drugs have been prevented ankylosis, but non steroidal anti inflammatory drugs (NSAIDs) are the first line drugs and these are very effective in most of patients who have inflammatory back pain. In recent years, reports that long-term use of NSAIDs may reduce the ankylosis are coming out and expect NSAIDs as anti ankylosis drugs. If NSAIDs is not effective, anti TNF agents can be used in severe inflammatory back pain. In peripheral arthritis, sulfasalazine or steoids can be used, and If these are failed, anti TNF agents can be used.

Keywords

References

  1. Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. [Epub] http://dx.doi.org/10.1136/annrheumdis-2013-203419.
  2. Zochling J, van der Heijde D, Dougados M, Braun J. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 2006;65:423-432. https://doi.org/10.1136/ard.2005.041129
  3. Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2008;(2):CD002822.
  4. Alaranta H, Luoto S, Konttinen YT. Traumatic spinal cord injury as a complication to ankylosing spondylitis: an extended report. Clin Exp Rheumatol 2002;20:66-68.
  5. Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'dell JR. Kelley's Textbook of Rheumatology. 9th ed. Philadelphia: Elsevier Saunders, 2011.
  6. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw-Hill, 2012.
  7. Kroon F, Landewé R, Dougados M, van der Heijde D. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:1623-1629. https://doi.org/10.1136/annrheumdis-2012-201370
  8. Haroon N, Kim TH, Inman RD. NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms? Ann Rheum Dis 2012;71:1593-1595. https://doi.org/10.1136/annrheumdis-2012-201844
  9. Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011;70:896-904. https://doi.org/10.1136/ard.2011.151027
  10. Haibel H, Sieper J. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker? Curr Opin Rheumatol 2010;22:388-392. https://doi.org/10.1097/BOR.0b013e32833aaf93
  11. Rudwaleit M, Claudepierre P, Wordsworth P, et al. Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis. J Rheumatol 2009;36:801-808. https://doi.org/10.3899/jrheum.081048
  12. Korea Centers for Disease Control and Prevetion. Korean Guidelines for Tuberculosis. Seoul: KCDC, 2011:175-179.
  13. Her M, Kavanaugh A. Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors. Curr Opin Rheumatol 2013;25:455-459. https://doi.org/10.1097/BOR.0b013e3283620177

Cited by

  1. 강직성 척추염의 침 치료에 대한 최근 연구동향 분석: China National Knowledge Infrastructure 검색을 중심으로 vol.30, pp.4, 2013, https://doi.org/10.18325/jkmr.2020.30.4.79